Allogene Therapeutics (ALLO)
(Delayed Data from NSDQ)
$2.72 USD
+0.17 (6.46%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $2.73 +0.01 (0.37%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC11/7/24 |
---|---|
Current Quarter | -0.34 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | 8.57% |
ABR | 1.61 |
Earnings ESP
|
-7.20% |
---|---|
Current Year | -1.41 |
Next Year | -1.45 |
EPS (TTM) | -1.50 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.04M | 0.04M | 0.07M | 0.16M |
# of Estimates | 3 | 3 | 7 | 5 |
High Estimate | 0.05M | 0.05M | 0.12M | 0.20M |
Low Estimate | 0.03M | 0.03M | 0.02M | 0.10M |
Year ago Sales | 0.04M | 0.02M | 0.16M | 0.07M |
Year over Year Growth Est. | 7.50% | 115.00% | -55.62% | 125.35% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.34 | -0.36 | -1.41 | -1.45 |
# of Estimates | 12 | 11 | 9 | 12 |
Most Recent Consensus | -0.36 | -0.32 | -1.47 | -1.56 |
High Estimate | -0.30 | -0.32 | -1.35 | -1.29 |
Low Estimate | -0.36 | -0.42 | -1.47 | -1.66 |
Year ago EPS | -0.37 | -0.43 | -2.01 | -1.41 |
Year over Year Growth Est. | 8.11% | 16.28% | 29.85% | -3.04% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.34 | -0.36 | -1.41 | -1.45 |
7 Days Ago | -0.34 | -0.36 | -1.41 | -1.45 |
30 Days Ago | -0.34 | -0.36 | -1.41 | -1.46 |
60 Days Ago | -0.34 | -0.36 | -1.41 | -1.46 |
90 Days Ago | -0.36 | -0.38 | -1.47 | -1.58 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.36 | -0.36 | -1.47 | -1.56 |
Zacks Consensus Estimate | -0.34 | -0.36 | -1.41 | -1.45 |
Earnings ESP | -7.20% | 0.00% | -4.34% | -7.46% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.38 | -0.43 | -0.37 | NA |
Estimate | -0.35 | -0.38 | -0.47 | -0.53 | NA |
Difference | 0.03 | 0.00 | 0.04 | 0.16 | 0.06 |
Surprise | 8.57% | 0.00% | 8.51% | 30.19% | 11.82% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more